Israeli cancer breakthrough says which patients should get immunotherapy

Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.

Related Keywords

Ashkelon ,Hadarom ,Israel ,Beersheba ,Angel Porgador ,Moshe Elkabets ,Orli Abramov ,Faculty Of Health Sciences ,Barzilai Medical Center ,Ben Gurion University Of The Negev ,Soroka University Medical Center ,Ben Gurion University ,Science Advances ,Bar Kaufman ,Health Sciences ,